ArticleOncology letters2023

Effects of BRAF V600E and NRAS mutational status on the progression-free survival and clinicopathological characteristics of patients with melanoma.

Tatjana Zablocka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.